Grimes & Company, Inc. Becton Dickinson & CO Transaction History

Grimes & Company, Inc.

$3.58 Billion
Q2 2025

A detailed history of Grimes & Company, Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Grimes & Company, Inc. holds 1,472 shares of BDX stock, worth $284,832. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,472

Previous 1,328 10.84%

Holding current value

$284,832

Previous $304,000 16.78%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 22, 2025	BUY	$165.15 - $226.42 $23,781 - $32,604	144 Added 10.84%	1,472 $253,000
Q1 2025 Apr 17, 2025	BUY	$222.79 - $249.08 $8,911 - $9,963	40 Added 3.11%	1,328 $304,000
Q4 2024 Jan 21, 2025	BUY	$220.02 - $243.75 $440 - $487	2 Added 0.16%	1,288 $292,000
Q3 2024 Oct 22, 2024	SELL	$221.47 - $242.41 $4,872 - $5,333	-22 Reduced 1.68%	1,286 $310,000
Q2 2024 Jul 22, 2024	SELL	$225.07 - $246.17 $70,446 - $77,051	-313 Reduced 19.31%	1,308 $305,000
Q1 2024 Apr 17, 2024	BUY	$233.45 - $247.73 $1,400 - $1,486	6 Added 0.37%	1,621 $401,000
Q4 2023 Jan 24, 2024	BUY	$232.24 - $267.23 $59,453 - $68,410	256 Added 18.84%	1,615 $393,000
Q3 2023 Oct 19, 2023	BUY	$254.9 - $283.59 $1,019 - $1,134	4 Added 0.3%	1,359 $351,000
Q2 2023 Jul 19, 2023	SELL	$238.39 - $265.32 $1,430 - $1,591	-6 Reduced 0.44%	1,355 $357,000
Q1 2023 Apr 20, 2023	SELL	$229.71 - $259.35 $53,752 - $60,687	-234 Reduced 14.67%	1,361 $336,000
Q4 2022 Jan 25, 2023	SELL	$218.29 - $256.91 $1,746 - $2,055	-8 Reduced 0.5%	1,595 $0
Q3 2022 Oct 28, 2022	SELL	$51.03 - $264.23 $108,132 - $559,903	-2,119 Reduced 56.93%	1,603 $357,000
Q2 2022 Jul 22, 2022	SELL	$234.74 - $275.42 $3.76 Million - $4.41 Million	-16,023 Reduced 81.15%	3,722 $918,000
Q1 2022 May 06, 2022	BUY	$243.64 - $270.48 $585,466 - $649,963	2,403 Added 13.86%	19,745 $5.25 Million
Q4 2021 Feb 01, 2022	BUY	$230.08 - $250.94 $154,153 - $168,129	670 Added 4.02%	17,342 $4.36 Million
Q3 2021 Nov 08, 2021	BUY	$232.72 - $256.47 $565,509 - $623,222	2,430 Added 17.06%	16,672 $4.1 Million
Q2 2021 Aug 04, 2021	BUY	$232.65 - $254.58 $2.99 Million - $3.27 Million	12,831 Added 909.36%	14,242 $3.46 Million
Q1 2021 May 12, 2021	SELL	$232.09 - $256.88 $41,079 - $45,467	-177 Reduced 11.15%	1,411 $343,000
Q2 2020 Jul 31, 2020	SELL	$219.9 - $263.41 $1,979 - $2,370	-9 Reduced 0.56%	1,588 $380,000
Q1 2020 May 05, 2020	BUY	$195.69 - $279.01 $33,071 - $47,152	169 Added 11.83%	1,597 $367,000
Q4 2019 Feb 05, 2020	BUY	$236.45 - $266.82 $53,201 - $60,034	225 Added 18.7%	1,428 $389,000
Q1 2019 May 02, 2019	BUY	$206.05 - $248.17 $30,289 - $36,480	147 Added 13.92%	1,203 $300,000
Q4 2018 Feb 01, 2019	BUY	$204.73 - $257.93 $31,528 - $39,721	154 Added 17.07%	1,056 $238,000
Q2 2018 Aug 10, 2018	BUY	$208.1 - $233.85 $187,706 - $210,932	902 New	902 $216,000

Others Institutions Holding BDX

# of Institutions

1,724

Shares Held

253M

Call Options Held

3.22M

Put Options Held

818K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $55.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grimes & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Grimes & Company, Inc. with notifications on news.

Account

Grimes & Company, Inc. Becton Dickinson & CO Transaction History